A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
SciTech Development, Inc.
4SC AG
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Progen Pharmaceuticals
Morphotek